5-Alpha reductase deficiency: a 40-year retrospective review
- PMID: 25321150
- DOI: 10.1097/MED.0000000000000116
5-Alpha reductase deficiency: a 40-year retrospective review
Abstract
Purpose of review: 5-Alpha reductase is an enzyme responsible for the conversion of testosterone to dihydrotestosterone. This key enzyme is responsible for triggering masculinization of the male external genitalia. Discovery of 5-alpha reductase deficiency as a syndrome of disordered male sexual development led to our molecular understanding of the role that this key enzyme plays in male sexual differentiation. This article will review the clinical and molecular history behind the discovery of 5-alpha reductase deficiency.
Recent findings: Three different genes encoding for 5-alpha reductase have been identified, with 5-alpha reductase type 2 being implicated in disordered male sexual development.
Summary: The discovery of 5-alpha reductase deficiency has not only shed light on the crucial role of 5-alpha reductase, testosterone, and dihydrotestosterone in male sexual differentiation but it also has facilitated the discovery of novel therapeutic applications of 5-alpha reductase inhibitors in clinical practice.
Similar articles
-
Steroid 5 alpha-reductase 2 deficiency.Endocr Rev. 1993 Oct;14(5):577-93. doi: 10.1210/edrv-14-5-577. Endocr Rev. 1993. PMID: 8262007 Review.
-
[Differentiation of external genitalia and 5 alpha-reductase].Nihon Rinsho. 2004 Feb;62(2):275-80. Nihon Rinsho. 2004. PMID: 14968532 Review. Japanese.
-
Role of testosterone binding to the androgen receptor in male sexual differentiation of patients with 5 alpha-reductase deficiency.J Steroid Biochem. 1979 Oct;11(4):1385-92. doi: 10.1016/0022-4731(79)90110-9. J Steroid Biochem. 1979. PMID: 513759 No abstract available.
-
Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase.J Clin Invest. 1992 Jan;89(1):293-300. doi: 10.1172/JCI115574. J Clin Invest. 1992. PMID: 1345916 Free PMC article.
-
Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.Horm Res. 2004;62(5):259-64. doi: 10.1159/000081893. Epub 2004 Nov 2. Horm Res. 2004. PMID: 15528927
Cited by
-
Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells.Nat Commun. 2024 Sep 3;15(1):7675. doi: 10.1038/s41467-024-52032-y. Nat Commun. 2024. PMID: 39227594 Free PMC article.
-
Persistent Gynecomastia due to Short-term Low-dose Finasteride for Androgenetic Alopecia.JCEM Case Rep. 2024 Apr 24;2(5):luae050. doi: 10.1210/jcemcr/luae050. eCollection 2024 May. JCEM Case Rep. 2024. PMID: 38660487 Free PMC article. Review.
-
Virilization at puberty in adolescent girls may reveal a 46,XY disorder of sexual development.Endocr Connect. 2023 Nov 8;12(12):e230267. doi: 10.1530/EC-23-0267. Print 2023 Dec 1. Endocr Connect. 2023. PMID: 37855374 Free PMC article.
-
Dermatologic care of patients with differences of sex development.Int J Womens Dermatol. 2023 Sep 5;9(3):e106. doi: 10.1097/JW9.0000000000000106. eCollection 2023 Oct. Int J Womens Dermatol. 2023. PMID: 37671254 Free PMC article. Review.
-
46, XY 5-Alpha Reductase Deficiency in a 36-Year-Old Phenotypic Female Patient.AACE Clin Case Rep. 2022 Apr 25;9(2):53-54. doi: 10.1016/j.aace.2022.04.006. eCollection 2023 Mar-Apr. AACE Clin Case Rep. 2022. PMID: 37056410 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
